Tough to accept but so far their predictions and assessments have been pretty spot on with the CYDY shareprice being the measurement that counts to me.

It isn't a knock on leronlimab at all but we have proof positive the management crew of Kelly, Pourhassan, Mulholland and Colachis was an incompetent group. When combined with the disaster Amarex situation, what a shit show.


Today is Dr Pourhassan's last chance to make a good impression as far as I am concerned. I admire his tenacity and his clear desire to help patients who could benefit from leronlimab. Still, if he isn't able to turn this around, he needs to step back and take another role in the company. IMO.